Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In clinical trials of Wegovy, which included a higher dose of injectable semaglutide (2.4 mg), people lost an average of almost 15 percent of their body weight
As treatment extends beyond three years, clinicians must consider how gastrointestinal tolerability evolves over time
These conditions or factors are referred to as contraindications
Through the application of PTE and Patent Term Adjustment (PTA), Novo Nordisk succeeded in pushing the expiration of the 343 patent to December 5, 2031
US$ 20.11
US$ 25.51
US$ 21.71
US$ 20.79
US$ 24.19
US$ 24.40
US$ 23.92
US$ 20.13
US$ 26.03
US$ 27.82
